US-based company with R&D branch near Jerusalem invents new technology to identify tumors rapidly, accurately and without radiation
Yifa Yaakov
The Times of Israel
5/1/2014
A Miami-based medical technology company with an R&D subsidiary in Moshav Ora, near Jerusalem, has developed an easy, non-invasive method to detect breast cancer early on – using a simple blood test.
In its laboratories near the capital, Eventus Diagnostics (EventusDx) has developed what it describes as an accurate, cost-effective, immune system-based means of detecting the presence of cancer in the breast tissue.
The Octava tests, which measure cancer-specific antibodies produced by the immune system in response to the growth of tumors, can be used to quickly diagnose breast cancer and identify false negative mammogram results…
The article continues at The Times of Israel.
